Alsonex Pharmaceuticals is developing a peptide inhibitor of complement factor C5aR1 for the treatment of neurodegenerative diseases including Alzheimer's Disease, Parkinson's Disease and Amyotrophic Lateral Sclerosis.
Headquarters:
Australia
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2016 (10 years)
Employees by Department
- Sales (1)
- The Rest (0)
- Total (1)
Key Decision Makers
Financials
LOW
spending power
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has ALSONEX PTY. LTD. been operating for?
- What is the funding status of ALSONEX PTY. LTD.?
- Where is ALSONEX PTY. LTD.'s headquarter?
- What ALSONEX PTY. LTD.'s spending power?
- Does ALSONEX PTY. LTD. have a presence in the domain it operates in?
